No Data
Investors Interested In Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Revenues
When you see that almost half of the companies in the Life Sciences industry in the United States have price-to-sales ratios (or "P/S") below 3.4x, Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) lo
Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Maravai LifeSciences | 10-Q: Quarterly report
Express News | Maravai LifeSciences Holdings Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reaffirmed FY24 Revenue Guidance. Also, Baird Maintained an Outperform Rating on the Stock and Raised Its Price Target...
Express News | Maravai LifeSciences Holdings Inc : UBS Raises Target Price to $8.5 From $6.5
Maravai Lifesciences: A Strong Buy on Strategic Positioning and Operational Leverage